O	0	3	The
O	4	11	natural
O	12	19	history
O	20	22	of
B-Disease	23	34	retinopathy
O	35	37	in
B-Disease	38	45	insulin
I-Disease	45	46	-
I-Disease	46	55	dependent
I-Disease	56	64	juvenile
I-Disease	64	65	-
I-Disease	65	70	onset
I-Disease	71	79	diabetes
O	79	80	.

O	82	84	We
O	85	95	determined
O	96	99	the
O	100	105	cross
O	105	106	-
O	106	115	sectional
O	116	123	natural
O	124	131	history
O	132	134	of
B-Disease	135	146	retinopathy
O	147	149	by
O	150	161	prospective
O	162	167	study
O	168	170	of
O	171	174	461
B-Disease	175	182	insulin
I-Disease	182	183	-
I-Disease	183	192	dependent
I-Disease	193	201	juvenile
I-Disease	201	202	-
I-Disease	202	207	onset
I-Disease	208	217	diabetics
O	217	218	.

O	219	221	In
O	222	224	so
O	225	230	doing
O	230	231	,
O	232	234	we
O	235	243	compared
O	244	247	the
O	248	259	sensitivity
O	260	262	of
B-Diagnostic_tool	263	277	ophthalmoscopy
O	277	278	,
B-Diagnostic_tool	279	290	photography
O	290	291	,
O	292	295	and
B-Diagnostic_tool	296	307	fluorescein
I-Diagnostic_tool	308	319	angiography
O	320	322	in
O	323	332	detecting
B-Disease	333	344	retinopathy
O	344	345	.

B-Diagnostic_tool	346	357	Photography
O	358	361	was
O	362	365	far
O	366	370	more
O	371	379	reliable
O	380	384	than
B-Diagnostic_tool	385	399	ophthalmoscopy
O	400	402	in
O	403	412	detecting
B-Disease	413	418	early
I-Disease	419	430	retinopathy
O	431	434	and
O	435	445	equivalent
O	446	448	to
B-Diagnostic_tool	449	460	angiography
O	460	461	.

B-Disease	462	473	Retinopathy
O	474	477	was
O	478	481	not
O	482	489	present
O	490	492	at
O	493	502	diagnosis
O	503	505	of
B-Disease	506	514	diabetes
O	514	515	.

O	516	521	After
O	522	523	a
O	524	527	lag
O	528	534	period
O	534	535	,
O	536	539	the
O	540	550	prevalence
O	551	553	of
B-Disease	554	565	retinopathy
O	566	570	rose
O	571	573	in
O	574	583	sigmoidal
O	584	591	fashion
O	591	592	,
O	593	601	reaching
O	602	604	50
O	604	605	%
O	606	608	at
O	609	613	just
O	614	618	over
O	619	624	seven
O	625	630	years
O	631	639	duration
O	639	640	,
O	641	644	and
O	645	659	asymptotically
O	660	671	approaching
O	672	674	90
O	674	675	%
O	676	678	at
O	679	681	17
O	681	682	-
O	682	683	-
O	683	685	50
O	686	691	years
O	691	692	.

B-Disease	693	706	Proliferative
I-Disease	707	718	retinopathy
O	719	722	was
O	723	728	first
O	729	733	seen
O	734	736	at
O	737	739	13
O	740	745	years
O	746	754	duration
O	754	755	,
O	756	759	and
O	760	763	its
O	764	774	prevalence
O	775	779	rose
O	780	782	to
O	783	785	26
O	785	786	%
O	787	789	at
O	790	792	26
O	792	793	-
O	793	794	-
O	794	796	50
O	797	802	years
O	802	803	.

O	804	808	From
O	809	812	the
O	813	820	natural
O	821	828	history
O	829	831	we
O	832	840	computed
O	841	844	the
O	845	855	dimensions
O	856	858	of
O	859	860	a
O	861	869	proposed
O	870	878	clinical
O	879	884	trial
O	885	887	to
O	888	892	test
O	893	896	the
O	897	903	effect
O	904	906	of
O	907	912	tight
O	913	922	metabolic
O	923	930	control
O	931	933	in
O	934	944	prevention
O	945	947	of
B-Disease	948	959	retinopathy
O	959	960	.
